BCG SSI

DRUG3 trials

Sponsors

University of Oxford, Aeras

Conditions

Tuberculosis

Phase 1

A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults

CompletedNCT02420444

AerasTuberculosis

Start: 2011-01-31End: 2013-11-30Updated: 2017-01-24

Unknown Phase

A Clinical Challenge Study of BCG in Healthy Volunteers

CompletedNCT02088892

University of OxfordTuberculosis

Start: 2014-03-31End: 2015-01-31Updated: 2015-01-22

Heterologous Effects of BCG in Healthy UK Adults

CompletedNCT02380508

University of OxfordTuberculosis

Start: 2015-02-28End: 2016-11-30Updated: 2016-11-30

Related Papers

Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study

Scientific Reports2022-05-126 citations

Optimization of a Human Bacille Calmette-Guérin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity

The Journal of Infectious Diseases2015-10-0834 citations